FDAnews Drug Daily Bulletin

ASPREVA SEES 1Q REVENUE OF $62 MILLION

April 14, 2006
A A

Pharmaceutical company Aspreva Pharmaceuticals Corp. said Thursday it expects to report first-quarter revenue of about $62 million, aided by a higher-than-expected payment under its collaboration agreement with Roche Holding Ltd.
Business Week